ArticleEnvironmental microbiology reports2026
Migratory Birds Facilitate the Spread of Multidrug-Resistant Pathogenic Escherichia coli in Tanguar Haor of Bangladesh.
Article in Environmental microbiology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study investigated the occurrence of pathogenic and multidrug-resistant (MDR) Escherichia coli in migratory birds inhabiting wetland habitats. A total of 167 freshly voided faecal samples were collected from migratory birds during the winters of 2023 and 2024. Isolation and identification of E. coli were performed using standard cultural and molecular techniques. Antimicrobial susceptibility testing was performed against 19 antibiotics, followed by the detection of resistance genes. Overall, the E. coli detection rate was 68.62% and 46.15% in 2023 and 2024, respectively. Multiple diarrheagenic E. coli pathotypes (ETEC, EAEC, EHEC, EPEC and EIEC) were identified, where the isolates from 2023 showed greater diversity. Most of the E. coli isolates were identified as MDR, with MDR patterns being more frequent in 2024. Resistance genes associated with tetracycline, β-lactam and aminoglycoside antibiotics, where tetB, tetO, tetC, bla
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.